DE69507408D1 - Peptide mit Affinität zu Tumoren und diese enthaltende radioaktive diagnostische und therapeutische Zusammensetzungen - Google Patents

Peptide mit Affinität zu Tumoren und diese enthaltende radioaktive diagnostische und therapeutische Zusammensetzungen

Info

Publication number
DE69507408D1
DE69507408D1 DE69507408T DE69507408T DE69507408D1 DE 69507408 D1 DE69507408 D1 DE 69507408D1 DE 69507408 T DE69507408 T DE 69507408T DE 69507408 T DE69507408 T DE 69507408T DE 69507408 D1 DE69507408 D1 DE 69507408D1
Authority
DE
Germany
Prior art keywords
amino acid
acid sequence
affinity
radioactive
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69507408T
Other languages
English (en)
Other versions
DE69507408T2 (de
Inventor
Ikuya Seki
Yoshitoshi Itaya
Yoshifumi Shirakami
Komei Washino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Publication of DE69507408D1 publication Critical patent/DE69507408D1/de
Application granted granted Critical
Publication of DE69507408T2 publication Critical patent/DE69507408T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69507408T 1994-06-07 1995-06-06 Peptide mit Affinität zu Tumoren und diese enthaltende radioaktive diagnostische und therapeutische Zusammensetzungen Expired - Fee Related DE69507408T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14865594 1994-06-07

Publications (2)

Publication Number Publication Date
DE69507408D1 true DE69507408D1 (de) 1999-03-04
DE69507408T2 DE69507408T2 (de) 2000-05-18

Family

ID=15457667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69507408T Expired - Fee Related DE69507408T2 (de) 1994-06-07 1995-06-06 Peptide mit Affinität zu Tumoren und diese enthaltende radioaktive diagnostische und therapeutische Zusammensetzungen

Country Status (11)

Country Link
US (1) US5827498A (de)
EP (1) EP0700930B1 (de)
KR (1) KR960000250A (de)
AT (1) ATE175977T1 (de)
AU (1) AU684348B2 (de)
CA (1) CA2151099A1 (de)
DE (1) DE69507408T2 (de)
DK (1) DK0700930T3 (de)
ES (1) ES2138111T3 (de)
MC (1) MC2397A1 (de)
TW (1) TW394777B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2165228A1 (en) * 1994-12-27 1996-06-28 Yoshitoshi Itaya Metal chelate forming peptides and use thereof
ES2804476T3 (es) * 2010-12-14 2021-02-08 Recepta Biopharma S A Péptido antitumoral derivado de una región determinante de complementariedad de un anticuerpo monoclonal humanizado contra el transportador NaPI2B
CN104519898A (zh) 2012-06-06 2015-04-15 国家健康与医学研究院 用于治疗癌症的方法和药物组合物
CN111225679B (zh) * 2017-08-19 2024-03-29 俄亥俄州创新基金会 新型基于肽的癌症显像剂
CN107550864B (zh) * 2017-08-23 2020-12-18 科笛生物医药(上海)有限公司 Eppt多肽-聚乙二醇-磷脂复合膜材料、其制备方法及主动靶向脂质体递药系统和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322678A (en) * 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
JPH04501719A (ja) * 1988-11-10 1992-03-26 インペリアル・キヤンサー・リサーチ・テクノロジー・リミテツド ポリペプチド
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
DK0570493T3 (da) * 1991-02-08 2000-06-26 Diatide Inc Technetium-99m-mærkede polypeptider til billeddannelse.
GB9108652D0 (en) * 1991-04-23 1991-06-12 Antisoma Ltd Immunoreactive compounds

Also Published As

Publication number Publication date
ES2138111T3 (es) 2000-01-01
US5827498A (en) 1998-10-27
KR960000250A (ko) 1996-01-25
TW394777B (en) 2000-06-21
DE69507408T2 (de) 2000-05-18
ATE175977T1 (de) 1999-02-15
CA2151099A1 (en) 1995-12-08
AU684348B2 (en) 1997-12-11
EP0700930A1 (de) 1996-03-13
DK0700930T3 (da) 1999-09-13
MC2397A1 (fr) 1996-07-26
EP0700930B1 (de) 1999-11-03
AU2049995A (en) 1995-12-14

Similar Documents

Publication Publication Date Title
MX9709913A (es) Metaloconstrucciones determinadas estructuralmente y aplicaciones.
MX9707430A (es) Complejos radiofarmaceuticos ternarios.
ES2146213T3 (es) Compuestos de porficeno para terapia fotodinamica.
DK197386A (da) Terapeutiske praeparater til brug ved fotodiagnose og fototerapi
AU579387B2 (en) New tetrapyrrole therapeutic agents
IT1299175B1 (it) Composizione contenente radioisotopi immobilizzati su particelle solide, utile in particolare per la brachiterapia clinica in patologie
EP1289571A2 (de) Prochelators von radiometall markierte molekülen
AU2001277488A1 (en) Prochelators of radiometal labeled molecules
DE69507408T2 (de) Peptide mit Affinität zu Tumoren und diese enthaltende radioaktive diagnostische und therapeutische Zusammensetzungen
ES2096040T3 (es) Nuevo reactivo para la representacion grafica de los tumores y su terapia.
GR1002903B (el) Πεπτιδιο συγγενες με ογκο και ραδιενεργος διαγνωστικος παραγοντας και ραδιενεργος θεραπευτικος παραγοντας που περιεχει το πεπτιδιο.
EP0659764B1 (de) Peptide modifiziert durch eine Phosphin Gruppe zur Markierung mit 99mTC und 186-188Re oder paramagnetische Agentien
ATE89567T1 (de) Konjugate von vinblastin und seine derivate, verfahren zur herstellung derselben und diese konjugate enthaltende pharmazeutische zusammensetzungen.
US5798444A (en) Ligand precursors for incorporation into peptides
IL86722A (en) Guanidine-related compounds comprising a tetraphenylborate ion and their preparation
CA2172455A1 (en) Labelled compound
Jones Method of synthesis of vicinal diamines
JPH04149198A (ja) カルシトニン誘導体
IT1245352B (it) Mezzi di contrasto per imaging cardiaco
RU93048177A (ru) Новые 2-сахаринилметиларилкарбоксилаты, полезные в качестве ингибиторов протеолитических ферментов, и использование указанных соединений и композиция на их основе

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: IM HEFT 9/99, SEITE 2753, SP.3: DIE VEROEFFENTLICHUNG IST ZU STREICHEN

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee